On this page
- What gastroenterology billing involves
- Who this affects
- Screening versus diagnostic colonoscopy
- Modifier 33 and modifier PT
- What the patient owes
- Age, frequency, and eligibility checks
- Polypectomy and endoscopy coding
- The family hierarchy
- Upper and lower endoscopy in one session
- ASC, office, and hospital settings
- Anesthesia and pathology coordination
- Prior authorization in GI
- GI infusion drugs and drug billing
- Common denial patterns in gastroenterology
- Investigation steps when GI claims go unpaid
- How Mednex works with GI practices
- Mednex and practice responsibilities
- Records and access needed
- Quality checks and exceptions
- How progress is measured
- What cannot be promised
- Sources to verify
- Next steps
What gastroenterology billing involves
Gastroenterology billing is the process of turning a clinic visit, an endoscopy, or an infusion into a clean claim and following it through payment. The steps are the same as in any specialty: registration, eligibility, coding, charge entry, claim submission, posting, denial work, and patient statements. What differs is how often one encounter changes category after the fact. A screening colonoscopy can become a diagnostic or therapeutic one when a polyp is found, and the claim, the patient’s cost share, and the payer’s edits all change with it.
Four features set GI apart:
- Screening and diagnostic rules overlap. Preventive benefits, Medicare rules, and commercial plan rules each treat the same procedure differently.
- Endoscopy codes form families. Codes are built on a base procedure, and the most extensive service reported on a session follows hierarchy and bundling rules.
- Several parties bill one session. The gastroenterologist, the facility, the anesthesia group, and the pathology lab each send their own claim, and they must agree on the story.
- Drugs add a second business. Infusion therapy for inflammatory bowel disease brings drug codes, benefit investigation, and buy-and-bill or specialty pharmacy decisions.
For the broader process, see medical billing services and revenue cycle management.
Who this affects
- Independent GI groups that perform procedures in an office suite or an ambulatory surgery center (ASC)
- Hospital-based gastroenterologists who bill professional services only
- Practices with an in-house infusion suite for biologic therapy
- Practices that employ nurse practitioners or physician assistants for clinic visits
- Groups that own an ASC and must keep the professional and facility billing separate
- Practices that changed ownership or payer mix and now see new edit patterns
Screening versus diagnostic colonoscopy
A screening colonoscopy is done on a patient without symptoms to look for colorectal cancer or precancerous polyps. A diagnostic colonoscopy is done to evaluate symptoms, a positive test, or a known problem. The billing difference is large because preventive benefits are often covered with no patient cost sharing, while diagnostic services are subject to deductibles, copays, and coinsurance under many plans.
Modifier 33 and modifier PT
Two modifiers carry most of the weight, and which one applies depends on the payer:
- Modifier 33 (preventive services). The AMA created this CPT modifier to mark a service as preventive so that a plan can waive cost sharing under the Affordable Care Act. Many commercial payers use it on a screening colonoscopy that turns into a polypectomy.
- Modifier PT (colorectal cancer screening test converted to diagnostic or other procedure). Medicare uses this on the CPT code when a screening turns into a diagnostic or therapeutic procedure. Medicare also has G codes for screening colonoscopy, with separate codes for high-risk and not-high-risk patients, which apply when no polyp is removed.
Some payers use a diagnosis and procedure combination instead of a modifier to trigger the screening benefit. Others want the screening diagnosis first on the claim. Do not assume one payer’s method works on another. Put each payer’s required method in the payer profile and test it with a sample claim.
What the patient owes
Medicare waives cost sharing for screening colonoscopy when no polyp is removed. When a polyp is found and removed, current Medicare rules apply cost sharing, with a scheduled phase-down. Industry reports based on CMS rules describe a coinsurance of 15 percent for dates of service through the end of 2026, falling over later years to zero by 2030. Verify the current schedule on CMS.gov before quoting any figure to a patient. Commercial plans vary, and some waive cost sharing on a screening procedure even when a polyp is removed. Benefit verification should capture the plan’s rule before the procedure.
A patient who expects a free screening and receives a bill after polyp removal will call the practice, not the plan. A short scheduling script that explains the possibility, and a note in the chart that the discussion happened, prevents many calls. The practice writes the script. Mednex can supply the benefit details that go into it.
Age, frequency, and eligibility checks
The recommended starting age for average-risk screening was lowered to 45 by national guidance, and coverage rules have followed at different speeds. Check each plan’s age rule, the interval since the last colonoscopy, and whether the patient has risk factors that change the code or the interval. Medicare also covers other screening options, including stool-based tests and, in recent years, additions to the covered list. A positive result on a stool-based test can lead to a follow-on colonoscopy, and payer treatment of cost sharing for that follow-on study differs by program. Read the current CMS coverage pages and the plan’s policy.
Polypectomy and endoscopy coding
CPT codes are owned by the American Medical Association. The table below paraphrases a small set of commonly used codes. Check the current CPT book and payer policies for exact definitions.
| Code or family | General use | Billing note |
|---|---|---|
| 45378 | Diagnostic colonoscopy | Base code of the colonoscopy family |
| 45380 | Colonoscopy with biopsy | Biopsy of a lesion. One unit per session when the technique is the same, per CPT guidance |
| 45384 | Colonoscopy with polyp removal by hot biopsy forceps | A distinct technique from snare removal |
| 45385 | Colonoscopy with polyp removal by snare | Common therapeutic colonoscopy code |
| 45381 | Colonoscopy with submucosal injection | Add or separate depending on the payer’s edit rules |
| 43235, 43239 | Upper endoscopy, diagnostic and with biopsy | Often done in the same session as a colonoscopy |
| 91110 | Capsule endoscopy of the GI tract | Payers limit use to specific indications |
| 88305 | Pathology, tissue exam | Billed by the pathologist or lab, not the gastroenterologist |
| 99202 to 99215 | Office E/M visits | Level chosen by medical decision making or total time |
The family hierarchy
Endoscopy codes are organized so that the most extensive procedure on a session is reported, and less extensive services are not billed separately in addition. Within the colonoscopy family, a therapeutic code generally includes the diagnostic inspection. When more than one therapeutic technique is used in the same session, for example a snare removal of one polyp and a biopsy of another lesion, the codes for each distinct technique can be reported, usually with a modifier that signals a separate procedure. Which modifier, and whether the payer accepts it, depends on the National Correct Coding Initiative edits and the payer’s policy. Do not apply a modifier to override an edit without a clinical reason in the note.
The coder needs the procedure note to show:
- The extent of the exam, including whether the cecum was reached, and the reason if it was not
- Each lesion removed or biopsied, the location, and the technique used
- The indication, written so that the screening or diagnostic status is clear
- Any aborted or incomplete exam and the reason, since the code and the payment differ
- The pathology result linked to the specimen
Upper and lower endoscopy in one session
Patients often have an upper endoscopy and a colonoscopy under the same sedation. The codes for each are billed separately, with the appropriate diagnoses linked to each. A screening indication applies to the colonoscopy only. The upper endoscopy needs its own symptom or diagnosis, and the cost share for it applies on its own terms. Sloppy diagnosis linking here converts a clean screening claim into a denial or a patient complaint.
ASC, office, and hospital settings
The same procedure is paid differently depending on where it happens. The place of service on the claim must match the real site.
- Office (POS 11). The practice may bill nonfacility rates and, where applicable, supplies.
- Ambulatory surgery center (POS 24). The ASC bills a facility fee on its own claim. The physician bills the professional fee at the facility rate.
- Hospital outpatient department (POS 22). The hospital bills the facility. The physician bills professional services.
Industry reports on the 2026 Medicare physician fee schedule describe shifts in payment between office-based and facility-based endoscopy, because of changes to work values and practice expense. Treat that as a reason to review your own payer mix rather than a number to plan around. Check the current fee schedule files and your commercial contracts.
Groups that own an ASC need to keep two sets of books. The ASC claim, the professional claim, and the anesthesia claim all go to the same payer for the same session, and each has its own rules, identifiers, and timelines. A single registration error can cause all three to fail.
Anesthesia and pathology coordination
Two other claims sit next to the GI claim. They are billed by other parties, but their results affect yours.
- Anesthesia. Anesthesia services for colonoscopy have their own codes, including separate codes for screening and for non-screening colonoscopies, and a code for combined upper and lower procedures. The anesthesia group’s claim must tell the same story about the indication, or the plan may process the screening benefit on one claim and not the other.
- Pathology. The lab bills for tissue examination. A positive pathology result changes how the patient’s next colonoscopy is timed and coded. The patient may receive a bill from the lab, which may be outside the practice’s network, so notify patients of that possibility if the practice controls the lab choice.
- Consistency. If the GI claim says screening and the anesthesia claim says diagnostic, the plan will ask for records. Agree with the anesthesia group on how the indication is communicated.
The practice owns these relationships. Mednex can track which claims are paired, report the mismatches, and flag the payers where they repeat.
Prior authorization in GI
Routine screening colonoscopy often needs no authorization, but diagnostic procedures, advanced endoscopy, capsule studies, and many drugs do. Requirements vary by plan and change during the year.
- Verify whether the plan wants an authorization for each procedure code, including the therapeutic codes that might be needed if a polyp is found.
- Check whether the site of service must be a specific ASC or whether the plan steers procedures away from hospital outpatient departments.
- Track approvals for infusion drugs by drug, dose, number of infusions, and date range, because the plan may approve only a set period.
- Log peer-to-peer deadlines when the plan denies the request on medical necessity.
The clinical justification belongs to the physician. Mednex can submit requests, track status, and send reminders before the approval ends. See prior authorization services for the process, and the article on what prior authorization is for the concept.
GI infusion drugs and drug billing
Practices that give biologic infusions for Crohn’s disease or ulcerative colitis add a drug billing workflow. Drugs are billed with HCPCS J codes and similar drug codes, with units that depend on the dose and the drug’s billing unit. Examples include infliximab and vedolizumab, though the exact code, the biosimilar codes, and the units change over time, so check the current HCPCS file. See J codes in medical billing for the general approach.
The workflow has distinct steps:
- Benefit investigation. Confirm whether the drug is covered under the medical benefit or the pharmacy benefit, and whether the plan requires the drug to come from a specialty pharmacy.
- Authorization. Obtain approval for the drug and for the administration services, with dates and units.
- Administration codes. Report the infusion service separately from the drug, with documentation of start and stop times where the code depends on them.
- Waste and units. Record the amount given and the amount discarded, and bill according to the payer’s policy on wastage.
- Reconciliation. Match the drug invoice, the administration record, and the claim, because payments can be below the acquisition cost and the practice needs to see that quickly.
Drug billing creates financial exposure that clinic visits do not. A denied infusion claim can leave the practice with the drug cost and no payment, so authorization and eligibility checks matter more here than anywhere else in GI.
Common denial patterns in gastroenterology
| Pattern | Likely cause | First check |
|---|---|---|
| Screening benefit not applied | Modifier 33 or PT missing, or the screening diagnosis not listed first or linked | Payer rule for the screening flag and claim line modifiers |
| Frequency limit | Previous screening colonoscopy within the plan’s interval | Claim history and the plan’s interval |
| Bundled or denied as included | Add-on or second technique reported without support or without the right modifier | Procedure note and NCCI edit pair |
| Authorization missing | No approval for the procedure, the therapeutic code, or the drug | Authorization record and the codes billed |
| Medical necessity not met | Diagnosis does not meet the plan’s policy for the service | ICD-10-CM codes selected by the provider and the policy |
| Place of service mismatch | ASC or office rate billed for the wrong site | POS against the real location |
| Anesthesia claim conflicts | Indication differs between GI and anesthesia claims | Both claims and the procedure note |
| Drug units or wastage denied | Billing units do not match dose or payer policy | Administration record and drug code units |
For causes that cut across specialties, read why medical claims are denied. For follow-up after a denial, see denial management services.
Investigation steps when GI claims go unpaid
Problem. Endoscopy, visit, or infusion claims are denied, paid at a different level than expected, or sitting in A/R with no response.
Evidence to inspect. Denial and remittance reports for the last few months, A/R aging by payer, the authorization log, the procedure notes and pathology reports for a sample of claims, and the anesthesia and facility claims for the same sessions.
Likely causes. Screening and diagnostic status mismatches, modifier errors, bundling edits, authorization gaps, site of service mistakes, drug unit errors, or follow-up that stopped after the first denial.
Investigation steps.
- Group denials by remark and reason code, then by payer and CPT code. Find the causes behind most of the dollars first.
- For each cause, test five to ten claims against the procedure note, the pathology report, the authorization, and the payer policy.
- Pull the paired anesthesia and facility claims and compare the indications.
- Separate coding errors from registration and authorization errors, and from documentation errors.
- Check which unpaid claims are near the payer’s filing or appeal limits, which vary by payer and contract. Read the contract.
Corrective action. Correct and resubmit where the claim is wrong. Appeal where the payer’s decision conflicts with its own policy and the record supports the service. Hold claims when authorization or enrollment must be fixed first.
Submission and follow-up. Log every corrected claim and appeal with the date and a reference number, set the next follow-up date at the time of submission, and keep the original remittance with each appeal.
Prevention. Build payer-specific screening rules into charge entry, verify benefits and authorization at scheduling, and require the indication to be written clearly on the procedure note.
Measurement. Track denial rate by reason, days in A/R by payer, the share of procedure claims with the correct screening flag, and the share of infusion claims paid at or above acquisition cost. See clean claim rate and days in A/R for definitions.
How Mednex works with GI practices
- Review. Start with the Free Medical Billing Audit, which looks at a sample of claims, denial reasons, A/R aging by payer, and charge capture gaps.
- Setup. Document sites of service, providers, payers, screening rules by payer, and the infusion workflow if the practice has one.
- Access. Agree on how Mednex receives data. PHI moves only under a signed business associate agreement and through a secure workflow, not through the website form.
- Daily work. Eligibility checks, charge review against procedure notes, claim submission, payment posting, denial work, and A/R follow-up.
- Reporting. Reports on denials, A/R, and payer trends. Cadence and format are set with the practice.
Mednex and practice responsibilities
| Area | Mednex | Practice |
|---|---|---|
| Clinical documentation | Reviews notes against code requirements and raises questions | Writes, signs, and owns all procedure and visit notes |
| Code and modifier selection | Checks codes, modifiers, diagnosis links, and place of service against the note | Physician confirms the services and the indication |
| Claims and follow-up | Submits claims, tracks status, works denials and A/R | Answers documentation requests |
| Eligibility and authorization | Checks benefits, tracks approvals and expiration dates | Supplies clinical justification and joins peer-to-peer reviews |
| Patient cost share | Provides benefit details and follows the statement workflow | Explains possible cost changes to patients before procedures |
| Drug purchasing and inventory | Reconciles claims against administration records the practice supplies | Owns purchasing, storage, and administration records |
| Payer decisions | Submits appeals with supporting documentation | Accepts that payers decide coverage and payment |
Records and access needed
- Payer list with plan types and portal access
- Provider list with NPI, taxonomy, and payer enrollment status
- Sites of service, including ASC identifiers if the group owns one
- Fee schedule and contracted rates, if available
- Report exports: A/R aging, denial or remittance report, and charge detail for a recent period
- A sample of procedure notes with pathology results for the audit
- Authorization log with approval numbers, units, and dates, including infusion drugs
- Drug invoice and administration records if the practice runs an infusion suite
- Access to the EHR or practice management system, set up with limited permissions
Quality checks and exceptions
- Check the screening flag on every colonoscopy claim against the payer’s rule before it is sent.
- Compare the GI claim with the anesthesia and facility claims for each session in the audit sample.
- Review every claim that uses more than one endoscopy code against the note and the edit tables.
- Confirm the pathology report is linked to the right procedure and patient.
- Flag patients who may be inside a screening interval.
- Reconcile infusion claims to drug cost on a regular schedule.
- Keep one written reference for each payer’s exceptions, and update it when a policy changes.
Hypothetical example. A GI group notices that patients are calling about bills after polyp removal. These figures are an illustration only. A review shows that claims for one commercial payer went out with modifier PT instead of modifier 33. The fix is not to appeal each claim. The practice checks the payer’s policy, changes the charge rule for that payer, asks the payer whether corrected claims will be reprocessed, and adds a scheduling note that explains the possible cost change before the next procedure.
How progress is measured
- Denial rate by reason and payer, compared with a baseline from your reports
- Days in A/R by payer, with aging buckets
- Share of colonoscopy claims paid under the intended screening or diagnostic benefit
- Share of sampled sessions where GI, anesthesia, and facility claims agree on the indication
- Authorization related denials as a share of all denials
- Infusion claims paid compared with drug acquisition cost
- Appeals filed, decided, and overturned, reported as counts
These measures show process quality. They do not promise a particular collection result.
What cannot be promised
- That a payer will pay a claim, apply the screening benefit, or overturn a denial
- That an authorization request will be approved
- That a payer will accept a given modifier or code combination
- That Medicare and commercial rules on screening cost sharing will stay the same
- That a patient’s out-of-pocket cost will match any estimate
Mednex is not a law firm. Contract disputes, payer contract negotiation, and legal questions about ASC ownership or self-referral are outside the scope of billing services.
Sources to verify
Codes, modifiers, and cost sharing rules change. Before you rely on any statement on this page for a claim, check the primary source: the current AMA CPT code set, CMS.gov colorectal cancer screening coverage pages and the Medicare Claims Processing Manual, the NCCI edit tables, the HCPCS file for drug codes, the payer’s provider manual, and the payer’s screening policy. Filing and appeal windows differ by contract, so read the contract rather than assuming a number.
Next steps
Gather a recent A/R aging report, a denial or remittance report, and your payer list. Then request the Free Medical Billing Audit. Do not send patient records through the website form. You can also reach the team on the contact page, or browse other specialty billing pages. If you are weighing outside help, the guide to outsourcing medical billing versus in-house lists the factors to compare.
Frequently asked questions
What do gastroenterology billing services include?
They cover eligibility checks, charge review against procedure notes, claim submission, payment posting, denial work, A/R follow-up, and patient statements, with attention to GI issues: screening versus diagnostic status, modifiers 33 and PT, endoscopy code families, ASC and office place of service, coordination with anesthesia and pathology claims, and authorization for procedures and infusion drugs. The practice owns clinical notes and the indication, and Mednex checks claims against them. Scope is set at onboarding, so ask which of these tasks are included and which stay with your scheduling and clinical teams.
What is the difference between a screening and a diagnostic colonoscopy for billing?
A screening colonoscopy looks for cancer or polyps in a patient without symptoms, and many plans cover it as a preventive service with no patient cost share. A diagnostic colonoscopy evaluates symptoms, a positive test, or a known problem, and usually falls under the plan's deductible, copay, or coinsurance. The indication must be clear in the procedure note, because the claim, the modifiers, and the patient's bill all follow from it. Each payer sets its own rules for how to flag each type. A short note in the procedure report that states the indication in plain words, such as average-risk screening or surveillance after a prior polyp, prevents most disputes.
When do I use modifier 33 versus modifier PT?
Modifier 33 is the AMA's preventive services modifier, and many commercial payers use it to apply the screening benefit when a screening colonoscopy includes a polyp removal. Modifier PT is the Medicare approach for a colorectal cancer screening test that turns into a diagnostic or therapeutic procedure. Medicare also has separate G codes for screening colonoscopy without polyp removal. Some payers want a specific diagnosis order instead. Keep each payer's method in the payer profile and test it on a sample claim. If a payer processes the claim without the screening benefit, ask whether corrected claims will be reprocessed for the affected dates and keep the response in writing.
Why did a patient get a bill after a screening colonoscopy?
Usually because a polyp was removed or a biopsy was taken, which changes the service from screening to therapeutic or diagnostic under the plan's rules. Medicare waives cost sharing for screening colonoscopy when no polyp is removed, and applies cost sharing, on a scheduled phase-down, when one is removed. Some commercial plans waive it either way, and others do not. A claim flag error can also cause the bill. Check the plan's rule and the modifiers, and tell patients about the possibility before the procedure. Keep a short script for schedulers that explains the possible cost change and a chart note that the discussion took place, so billing staff can point to it later.
How are multiple polyps and multiple techniques coded?
Colonoscopy codes work as a family, and the most extensive procedure is reported. When different techniques are used in one session, such as a snare removal of one polyp and a biopsy of another lesion, each distinct technique can be reported, usually with a modifier showing a separate service. Same-technique removals are generally reported once per CPT guidance. Payers apply NCCI edits and their own policies, so the note must show each lesion, location, and technique. Check the current CPT book and edit tables. Write each payer's accepted modifier for a second technique in the payer profile, since the right choice differs and a wrong one can deny the whole line.
How do anesthesia and pathology claims affect the GI claim?
They are billed by other parties, but they must agree with your claim. Anesthesia has separate codes for screening and non-screening colonoscopy, so a mismatch in the indication can lead a plan to apply the screening benefit on one claim and not the other. Pathology is billed by the lab, and an out-of-network lab can send the patient a bill. Agree with the anesthesia group on how the indication is communicated, and notify patients if the practice controls the lab choice. A monthly check that compares the GI, facility, and anesthesia claims for the same sessions will surface repeat mismatches by payer.
Do GI procedures and infusions need prior authorization?
Routine screening colonoscopy often does not, but diagnostic procedures, advanced endoscopy, capsule studies, and many infusion drugs commonly do. Plans differ and change rules during the year, so verify at scheduling. Check whether approval covers the therapeutic codes that might be needed if a polyp is found, whether the plan requires a specific site of service, and the approved drug, dose, number of infusions, and dates. A denied infusion can leave the practice with the drug cost, so these checks matter. Peer-to-peer deadlines are short and set by the plan, so log them the day the denial arrives and assign a physician owner.
How is GI billing priced?
Pricing depends on scope, claim volume, the number of providers, whether the group owns an ASC, and whether infusion billing is included. Mednex does not publish rates on this page. Ask for the pricing model in writing, including what it covers, what costs extra, and how it changes with volume or sites. Ask how professional, facility, and infusion claims are handled, because a model that fits clinic visits can be a poor fit for procedure and drug billing. Ask whether the quote covers professional claims only or also facility and infusion claims, and who handles drug reconciliation against acquisition cost.
How long until I see results, and what can Mednex not promise?
It depends on payer turnaround, how many problems come from screening flags, modifiers, or authorization, and the age of existing A/R. Mednex does not promise a timeline, a collection outcome, a payer decision, an authorization approval, or any patient cost estimate. Early progress usually shows up as fewer screening flag denials and clearer denial reasons, which you can measure from your own reports. The Free Medical Billing Audit works from your own claim and A/R data. Mednex does not control payer decisions or patient cost estimates, so any promise that ignores those limits deserves a second look from the practice owner.
Sources
- KFF: Coverage of Colonoscopies Under the Affordable Care Act's Prevention Benefit
- Becker's ASC Review: What CMS colorectal cancer screening policy change means for ASC reimbursement in 2026
- Becker's ASC Review: Modifier 33 change in CMS Outpatient Code Editor
Payer rules vary by payer, plan, state and contract. Check the current policy before acting.